- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07698418
Effect of Inspiratory Muscle Training on Knee Osteoarthritis Pain
Effect of Inspiratory Muscle Training on Pain in Patients With Knee Osteoarthritis: A Randomized Controlled Trial
Knee osteoarthritis (KOA) is a common joint disease that causes chronic pain and limits daily activities. Current treatments, such as painkillers or surgery, have limitations like side effects or high costs. This study will test whether a safe, non-drug intervention-inspiratory muscle training (breathing exercises against resistance)-can reduce knee pain in people with KOA. The training may work by lowering inflammation and improving the brain's modulation of pain.
Eighty patients aged ≥55 years with confirmed KOA and frequent knee pain will be enrolled. Participants will be randomly assigned to either an 8-week inspiratory muscle training program (5 sessions per week, with gradually increasing resistance) or a sham (very low resistance) training program. Neither the patients nor the researchers assessing the outcomes will know who is in which group.
The main outcome is change in knee pain measured by a visual analog scale (VAS). Secondary outcomes include blood markers of inflammation (TNF-α, IL-6, IL1β), physical function, the Knee injury and Osteoarthritis Outcome Score (KOOS), inspiratory muscle strength, activity level, sleep quality, and quality of life. To explore underlying mechanisms, outcomes included heart rate variability (HRV) as an indicator of autonomic nervous system function, and brain functional connectivity in the prefrontal cortex using functional near-infrared spectroscopy (fNIRS) are collected. These mechanistic assessments will be performed at baseline and at the end of 8-week intervention. Additional follow-up assessments for clinical outcomes will be done at 3 and 6 months after the training ends. Any side effects or adverse events will be recorded.
This study will provide high-quality evidence on whether inspiratory muscle training is an effective and safe complementary treatment for knee pain in people with knee OA, and will offer new insights into the mechanisms underlying its analgesic effects.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Aged 55 years or older.
- Knee osteoarthritis (Kellgren-Lawrence grade ≥ 2).
- Knee pain (Visual Analogue Scale, VAS ≥ 3) on the most days in the past month.
- Able to walk independently without assitive devices.
Exclusion Criteria:
- History of knee replacement surgery, meniscus surgery, or ligament surgery.
- Received corticosteroid injection within the previous three weeks.
- Diagnosed with rheumatoid arthritis.
- Unstable angina, recent myocardial infarction, uncontrolled cardiac arrhythmia, or severe heart failure.
- History of stroke.
- Currently receiving steroid therapy, hormonal therapy, or cancer chemotherapy.
- Pneumothorax, pulmonary bullae, lung surgery within the past 12 months, unstable asthma, or severe dyspnea at rest.
- Unable to understand the study procedures and potential risks.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Verdreifachen
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Inspiratory Muscle Training
5 sessions/week for 8 weeks.
Load starts at 50% MIP for 40 reps, increases to 80% MIP for 60 reps from week 5, then adjusted weekly to 80% of updated MIP.
Device: threshold inspiratory muscle trainer.
|
Participants will perform home-based inspiratory muscle training using a threshold-loading device (POWERbreathe Medic Plus).
Training is conducted 5 times per week for 8 weeks.
The initial inspiratory load is set at 50% of the individual's maximum inspiratory pressure (MIP), measured weekly at the study site.
The load is progressively increased to 80% MIP over the first 4 weeks and maintained at 80% MIP for the remaining 4 weeks.
Each session consists of 40-60 breaths.
Adherence is monitored via an electronic training log and weekly on-site visits.
This protocol is individualized, progressive, and home-based, distinguishing it from fixed-load or supervised-only breathing interventions.
Andere Namen:
|
|
Schein-Komparator: Sham Inspiratory Muscle Training
Participants perform sham inspiratory muscle training with the same frequency and duration as the experimental group, but the inspiratory load is fixed at 10% of maximal inspiratory pressure (MIP) and does not progress.
All other procedures (weekly MIP measurement for sham load adjustment) are identical to maintain blinding.
|
Participants will perform home-based inspiratory muscle training using a threshold-loading device (POWERbreathe Medic Plus).
Training is conducted 5 times per week for 8 weeks.
The initial inspiratory load is set at 10% of the individual's maximum inspiratory pressure (MIP), measured weekly at the study site.
The load is maintained 10% MIP over 8 weeks.
Each session consists of 40-60 breaths.
Adherence is monitored via an electronic training log and weekly on-site visits.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Visual analogue scale
Zeitfenster: Baseline, week 8, 3-month after intervention, 6-month after intervention
|
Self-rated pain intensity of knee (0-100), "0" indicate no pain, "100" indicate worst pain.
|
Baseline, week 8, 3-month after intervention, 6-month after intervention
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Serum levels of inflammatory markers
Zeitfenster: Baseline, up to week 8
|
Systemic inflammation
|
Baseline, up to week 8
|
|
Heart rate variability
Zeitfenster: Baseline, up to week 8
|
Vagus nerve activity
|
Baseline, up to week 8
|
|
40-meter walk test
Zeitfenster: Baseline, up to week 8
|
Physical function
|
Baseline, up to week 8
|
|
30-sec chair stand test
Zeitfenster: Baseline, up to week 8
|
Physical function
|
Baseline, up to week 8
|
|
Pittsburgh Sleep Quality Index
Zeitfenster: Baseline, week 8, 3-month after intervention, 6-month after intervention
|
Total scores range from 0-21, '0' indicating no difficulty and '21' indicating severe difficulties in all areas.
|
Baseline, week 8, 3-month after intervention, 6-month after intervention
|
|
Maximal inspiratory pressure
Zeitfenster: Baseline, up to week 8
|
Inspiratory muscle strength
|
Baseline, up to week 8
|
|
The Knee injury and Osteoarthritis Outcome Score
Zeitfenster: Baseline, week 8, 3-month after intervention, 6-month after intervention
|
Patient-reported outcomes in pain, symptoms, daily living activities, sports and recreational activities, and quality of life, with the score of each subscale ranging from 0-100, where higher scores indicate worse conditions.
|
Baseline, week 8, 3-month after intervention, 6-month after intervention
|
|
Prefrontal cortex activity
Zeitfenster: Baseline, up to week 8
|
Functional near-infrared spectroscopy is used to assess prefrontal cortex activity
|
Baseline, up to week 8
|
|
Physical Activity Scales for the Elderly
Zeitfenster: Baseline, week 8, 3-month after intervention, 6-month after intervention
|
Total scores range from 0-793, where the higher scores indicate a higher level of physical activity.
|
Baseline, week 8, 3-month after intervention, 6-month after intervention
|
|
12-Item Short Form Health Survey
Zeitfenster: Baseline, week 8, 3-month after intervention, 6-month after intervention
|
Total scores range from 0-100, where the higher scores indicate better physical and mental health function.
|
Baseline, week 8, 3-month after intervention, 6-month after intervention
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Adherence
Zeitfenster: Up to week 8
|
Adherence is calculated from logbooks as completed versus prescribed sessions
|
Up to week 8
|
|
Adverse events
Zeitfenster: Up to week 8
|
Adverse events are defined as any symptom or abnormal sign during training and graded by the Common Terminology Criteria for Adverse Events (CTCAE v6.0, 2025): Mild: resolved with rest, no medical intervention; Moderate: require minimal medical intervention (e.g., analgesics); Severe: requires medical attention or hospitalization (e.g., clinic visit)
|
Up to week 8
|
Mitarbeiter und Ermittler
Mitarbeiter
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Schmerzen
- Neurologische Manifestationen
- Erkrankungen des Bewegungsapparates
- Arthritis
- Gelenkerkrankungen
- Rheumatische Erkrankungen
- Arthrose
- Pathologische Zustände, Anzeichen und Symptome
- Anzeichen und Symptome
- Arthrose, Knie
- Chronischer Schmerz
- Therapeutika
- Mind-Body-Therapien
- Komplementäre Therapien
- Bewegungsbewegungstechniken
- Physiotherapiemodalitäten
- Atemübungen
Andere Studien-ID-Nummern
- ZHSC-1-(2026)014
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Knie Arthrose
-
Gillian HatfieldLes Mills InternationalAktiv, nicht rekrutierendOsteoarthritis Knie und HüfteKanada
-
Anchen Pharmaceuticals, IncNovum Pharmaceutical Research ServicesAbgeschlossenOsteoarthritis des KniesVereinigte Staaten
-
University of PaviaAktiv, nicht rekrutierendOsteoarthritis KnieItalien
-
University of North Carolina, Chapel HillCenters for Disease Control and PreventionAnmeldung auf EinladungArthritis | Osteoarthritis KnieVereinigte Staaten
-
University of JaénAktiv, nicht rekrutierend
-
Robert Jones and Agnes Hunt Orthopaedic and District...Noch keine RekrutierungOsteoarthritis des KniesVereinigtes Königreich
-
Region SkaneGreta and Johan Kock FoundationRekrutierungOsteoarthritis des KniesSchweden
-
Singapore General HospitalAbgeschlossenOsteoarthritis des KniesSingapur
-
University of PaviaNoch keine RekrutierungOsteoarthritis Knie und Hüfte | Endoprothetik der unteren ExtremitätenItalien
-
Pleryon Therapeutics (Hangzhou) LimitedNoch keine RekrutierungOsteoarthritis des KniesAustralien
Klinische Studien zur Inspiratory muscle training
-
Elif KabasakalRekrutierungBronchiektasen | Funktionelles InspirationsmuskeltrainingTürkei (türkiye)
-
Ondokuz Mayıs UniversityNoch keine RekrutierungPhysiologische Leistung bei gesunden SportlerninnenTürkei (türkiye)
-
Burak KaracaUniversity of GaziantepAbgeschlossen
-
Sahmyook UniversityAbgeschlossenSubakuter Schlaganfall | BilanzdefiziteSüdkorea
-
Hacettepe UniversityRekrutierungPost-COVID-19-Syndrom | Kernstabilisierung | Funktionelles InspirationsmuskeltrainingTürkei (türkiye)
-
Al-Zaytoonah University of JordanAbgeschlossenIntervention bei akutem Schlaganfall | BeatmungspatientenÄgypten
-
Wroclaw University of Health and Sport SciencesRekrutierung
-
National Taiwan Normal UniversityNoch keine RekrutierungIntermittierendes Inspiratory Muscle Training | Eupnea
-
Izmir University of EconomicsAbgeschlossenBelastungsharninkontinenz (SUI)Truthahn
-
FATMA DİLARA AKAR ÇAMYARAbgeschlossen